Chemotherapeutic neuropathy

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.

Original languageEnglish (US)
Pages (from-to)565-571
Number of pages7
JournalCurrent Opinion in Neurology
Volume12
Issue number5
DOIs
StatePublished - 1999

Fingerprint

Vinca Alkaloids
Platinum Compounds
Suramin
Taxoids
Neurons
Drug Therapy
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chemotherapeutic neuropathy. / Windebank, Anthony John.

In: Current Opinion in Neurology, Vol. 12, No. 5, 1999, p. 565-571.

Research output: Contribution to journalArticle

@article{f3ea1950ddd34c46ae7b1d58a4a0d8a3,
title = "Chemotherapeutic neuropathy",
abstract = "Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.",
author = "Windebank, {Anthony John}",
year = "1999",
doi = "10.1097/00019052-199910000-00010",
language = "English (US)",
volume = "12",
pages = "565--571",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Chemotherapeutic neuropathy

AU - Windebank, Anthony John

PY - 1999

Y1 - 1999

N2 - Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.

AB - Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0033397107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033397107&partnerID=8YFLogxK

U2 - 10.1097/00019052-199910000-00010

DO - 10.1097/00019052-199910000-00010

M3 - Article

C2 - 10590893

AN - SCOPUS:0033397107

VL - 12

SP - 565

EP - 571

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 5

ER -